
Green Park & Golf Ventures
Description
Green Park & Golf Ventures (GPGV) is a Dallas, Texas-based venture capital firm with a strong emphasis on early-stage investments. The firm primarily targets promising companies within the healthcare, technology, and consumer sectors. Leveraging over 50 years of combined operational and financial experience, GPGV seeks out opportunities that demonstrate significant market potential and are led by exceptional management teams. Their investment approach is characterized by a commitment to supporting founders beyond capital infusion, aiming to foster growth through strategic guidance and network access.
GPGV's investment strategy centers on identifying innovative technologies and business models poised for disruption within their core sectors. They typically engage in seed and Series A funding rounds, providing initial capital ranging from $1 million to $5 million. This initial investment is often accompanied by reserves for subsequent follow-on rounds, indicating a long-term commitment to their portfolio companies' success. The firm's hands-on approach involves active collaboration with founders, utilizing their extensive network and operational expertise to help scale businesses and navigate market challenges.
With a robust portfolio, Green Park & Golf Ventures has made over 120 investments, demonstrating a consistent presence in the early-stage funding landscape. Their track record includes 19 successful exits, underscoring their ability to identify and nurture companies towards significant value creation. As lead investor in 14 funding rounds, GPGV often takes a prominent role in shaping the strategic direction of its portfolio companies, reflecting their belief in active partnership. Their focus on high-growth potential within critical sectors positions them as a key player in the venture ecosystem, particularly in the Southern US.
Investor Profile
Green Park & Golf Ventures has backed more than 92 startups, with 3 new investments in the last 12 months alone. The firm has led 12 rounds, about 13% of its total and boasts 11 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series A, Seed, Series Unknown rounds (top funding stages).
- Majority of deals are located in United States, Sweden, Germany.
- Strong thematic focus on Health Care, Medical, Biotechnology.
- Led 1 rounds in the past year.
- Typical check size: $1M – $5M.
Stage Focus
- Series A (32%)
- Seed (26%)
- Series Unknown (14%)
- Series B (14%)
- Series C (7%)
- Convertible Note (3%)
- Series E (1%)
- Angel (1%)
- Post Ipo Equity (1%)
- Series F (1%)
Country Focus
- United States (95%)
- Sweden (2%)
- Germany (2%)
- Israel (1%)
Industry Focus
- Health Care
- Medical
- Biotechnology
- Medical Device
- Software
- Health Diagnostics
- Manufacturing
- Information Technology
- Enterprise Software
- Artificial Intelligence (Ai)
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.